These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 23714668)

  • 1. [Expression and clinical significance of circadian gene Per2 in non-small cell lung cancer].
    Chi C; He ZF; Liu Y; Lin XM; Sun CC
    Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):129-31. PubMed ID: 23714668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression of Per1, Per2 and Per3 and their prognostic relevance in non-small cell lung cancer.
    Liu B; Xu K; Jiang Y; Li X
    Int J Clin Exp Pathol; 2014; 7(11):7863-71. PubMed ID: 25550826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and significance of PTEN/PI3K signal transduction-related proteins in non-small cell lung cancer].
    Liao DW; Wang L; Zhang XG; Liu MQ
    Ai Zheng; 2006 Oct; 25(10):1238-42. PubMed ID: 17059767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of AKT2, cyclin D1, and MMP-9 and their correlations to clinicopathologic features of non-small cell lung cancer].
    Wang J; Miao LJ; Wu YM; Wu YJ; Wang XC
    Ai Zheng; 2006 Jan; 25(1):69-72. PubMed ID: 16405753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of cyclin D1 and vascular endothelial growth factor(VEGF) in non-small cell lung carcinoma and their association with the prognosis].
    Liang RY; Liao ZS; Jiang SP; Zhang W; Li JG; Zheng DH
    Ai Zheng; 2003 Jan; 22(1):86-90. PubMed ID: 12561444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and significance of integrin alpha5, beta1 and E-CD in patients with non-small cell lung carcinoma].
    Guo QS; Jia H; Han MY; Yu JM; Zhong WX
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):746-9. PubMed ID: 17366785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression and mutation of Fas-associated death domain (FADD) gene in non-small cell lung cancer].
    Yang Q; Zhu RQ; Fang Z; Xia D; Diao LM; Liu MQ
    Ai Zheng; 2005 Mar; 24(3):321-6. PubMed ID: 15757534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CXCR4 and Nrf2 expressions in non-small cell lung cancer and their clinical implications].
    Hu T; Yao Y; Yu S; Guo H; Tian T; Han L; Wang W; Guo Q; Wang J; Nan K; Wang S
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Feb; 34(2):153-8. PubMed ID: 24589587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of Smac in Stage I-II non-small cell lung cancer and its clinical significance].
    Zhao JM; Zhu ZH; Wu QL; Hou JH; Huang XP; Zhang PY; Rong TH
    Ai Zheng; 2006 May; 25(5):631-4. PubMed ID: 16687088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of Merlin protein in non-small cell lung carcinoma and the clinical significance].
    Hu J; Wang L; Yu F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):565-9. PubMed ID: 21743150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of LYVE-1 and Prox-1 in non-small cell lung cancer and the relationship with lymph node metastasis].
    Chang C; Wang P; Yang H; Li L; Zhang LB
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):174-8. PubMed ID: 21500548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of ERCC1 mRNA and its impact on the prognosis of patients with non-small cell lung cancer].
    Ma W; Li W; Gao M; Li XN
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):371-4. PubMed ID: 21875468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
    Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H
    Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation between expression of forkhead box M1 (FOXM1) and clinicopathological features and prognosis in patients with non-small cell lung cancer (NSCLC)].
    Liu YQ; Guo RH; Liu LK; Gao W; Zhu CJ; Wei J; Shu YQ
    Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):426-30. PubMed ID: 21875482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of Smad4 and MAPK proteins in signal transduction pathway in non-small cell lung cancer].
    Tong XD; Liu HX; Zhao HR; Xu SG; Li Y; Han LB; Zhang L
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):741-5. PubMed ID: 17366784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian clock gene Per2 downregulation in non‑small cell lung cancer is associated with tumour progression and metastasis.
    Xiang R; Cui Y; Wang Y; Xie T; Yang X; Wang Z; Li J; Li Q
    Oncol Rep; 2018 Nov; 40(5):3040-3048. PubMed ID: 30226549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent loss of gelsolin expression in non-small cell lung cancers of heavy smokers.
    Dosaka-Akita H; Hommura F; Fujita H; Kinoshita I; Nishi M; Morikawa T; Katoh H; Kawakami Y; Kuzumaki N
    Cancer Res; 1998 Jan; 58(2):322-7. PubMed ID: 9443412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of special AT-rich sequence-binding protein mRNA and its clinicopathological significance in non-small cell lung cancer].
    Zhou LY; Liu F; Tong J; Chen QQ; Zhang FW
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):534-7. PubMed ID: 19304547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Robo1 expression in non-small cell lung cancer and its brain metastasis].
    Li XX; Jin L; Sun ZF; Gu F; Li WL; Ma YJ
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):198-201. PubMed ID: 23880000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.